SCHEMBL6561315

SCHEMBL6561315

O=S(=O)(Cl)c1ccc(-c2ccc(N3CCOCC3)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.58
TSHR P16473 1/20 0.58
KMT2A Q03164 5/20 0.49
ALDH1A1 P00352 5/20 0.49
MEN1 O00255 4/20 0.49
MAPT P10636 3/20 0.49
USP2 O75604 2/20 0.49
POLB P06746 4/20 0.49
GAA P10253 1/20 0.49
PIK3CA P42336 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
KDM4E B2RXH2 2/20 0.47
AKR1C3 P42330 1/20 0.47
JAK2 O60674 2/20 0.46
CNR2 P34972 1/20 0.46
JAK3 P52333 1/20 0.46
PTK2 Q05397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL540062 0.95 PKM (0.64) PKMTSHRKMT2AALDH1A1MEN1
SCHEMBL7652825 0.86 LMNA (0.54) PKMTSHRALDH1A1MAPTGAA
SCHEMBL7652722 0.84 LMNA (0.53) PKMTSHRKMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL7654927 0.83 PKM (0.58) PKMTSHRKMT2AALDH1A1MEN1
SCHEMBL17902921 0.81 ALDH1A1 (0.63) TSHRALDH1A1USP2KDM4ECYP1A2
SCHEMBL17899709 0.81 KMT2A (0.50) TSHRKMT2AALDH1A1MEN1MAPT
SCHEMBL3176219 0.80 LMNA (0.59) PKMTSHRALDH1A1MAPTKDM4E
SCHEMBL9581858 0.78 LMNA (0.58) PKMTSHRKMT2AALDH1A1MEN1
SCHEMBL9582446 0.78 LMNA (0.58) PKMTSHRKMT2AALDH1A1MEN1
SCHEMBL17902923 0.78 KDM4E (0.53) KMT2AALDH1A1MAPTGAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016107541-A1 PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 成都先导药物开发有限公司 2016-07-07 WO disclosed
WO-2016107544-A1 INTERMEDIATE COMPOUND FOR PREPARING PYRROLE AMIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF 成都先导药物开发有限公司 2016-07-07 WO disclosed
CN-105732459-A Pyrrole amide compounds, preparation method and applications thereof 成都先导药物开发有限公司 2016-07-06 CN disclosed
CN-105732597-A Intermediate compounds for preparing pyrrole amide compounds, preparation method and applications thereof 成都先导药物开发有限公司 2016-07-06 CN disclosed
EP-1124797-B1 N-ARYLSULFONYL AMINO ACID OMEGA AMIDES AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6339092-B1 FOR THERAPY RHEUMATOID ARTHRITIS, ARTHROSIS, TUMOUR INVASION AND GROWTH, INCLUDING MALIGNANT SPREAD AND THE FORMATION OF METASTASES, ULCERATIONS, ATHEROSCLEROSIS ADIR ET COMPAGNIE (FR) 2002-01-15 US disclosed
US-6335333-B1 MATRIX METALLOPROTEINASE INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-01 US disclosed
EP-1124797-A1 N-ARYLSULFONYL AMINO ACID OMEGA AMIDES Aventis Pharma Deutschland GmbH (DE) 2001-08-22 EP disclosed
US-6201130-B1 FOR THE THERAPY AND PROPHYLAXIS OF DISORDERS INVOLVING MATRIX-DEGRADING METALLOPROTEINASES; ANTIINFLAMMATORY AGENTS AVENTIS PHARMA DUETSCHLAND GMBH (DE) 2001-03-13 US disclosed
WO-2000027808-A1 N-ARYLSULFONYL AMINO ACID OMEGA AMIDES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-05-18 WO disclosed